Activating Intelligence: Getting More from Your PLD Today—and Tomorrow
HCP engagement starts with the right data—and physician-level data (PLD) is the powerhouse behind smarter segmentation and campaign optimization. Whether you're just getting started or leveling up, our guide has you covered.
Explore the results of OptimizeRx 2024 physician survey on pharma marketing perception and impact – including the untapped opportunity of HCP and DTC marketing alignment.
Oncologists Reveal Why ALK+ NSCLC Patients Switch Or Discontinue Treatment
We surveyed 25 U.S. medical oncologists to take a closer look at the key drivers of treatment discontinuation or switching in ALK+ NSCLC patients.
Download your copy of the report today to explore the factors that lead to treatment discontinuation, as well as how oncologists rank currently available ALK+ NSCLC treatments, so you can help your brand stand out.